{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:59:01Z","timestamp":1775123941360,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.antiviral.2006.03.007","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T23:28:31Z","timestamp":1144366111000},"page":"10-19","source":"Crossref","is-referenced-by-count":30,"title":["Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro"],"prefix":"10.1016","volume":"72","author":[{"given":"Nadejda","family":"Valiaeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Beadle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy A.","family":"Aldern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julissa","family":"Trahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Y.","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.03.007_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/mol.63.3.678","article-title":"Increased antiviral activity of 1-0-hexadecyloxypropyl-[2-14C] cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism","volume":"63","author":"Aldern","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2006.03.007_bib2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib3","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/jm050473m","article-title":"Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine (HPMPA) against cytomegalovirus and orthopoxviruses","volume":"49","author":"Beadle","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.03.007_bib4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/jo01323a017","article-title":"Prostaglandins and congeners. 20. Synthesis of prostaglandins via conjugate addition of lithium trans-1-alkenyltrialkylalanate reagents. A novel reagent for conjugate 1,4-additions","volume":"44","author":"Bernady","year":"1979","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.antiviral.2006.03.007_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/421912","article-title":"Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection","volume":"190","author":"Bidanset","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.03.007_bib6","unstructured":"Bischofberger, N.W., Kent, K.M., 1996. Method and cyclic carbonates for nucleotide analogs. US Patent 5,514,798."},{"key":"10.1016\/j.antiviral.2006.03.007_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model","volume":"318","author":"Buller","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.03.007_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterfication of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.03.007_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0006-2952(93)90670-R","article-title":"Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vero cells","volume":"46","author":"Connelly","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2006.03.007_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogs cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2006.03.007_bib11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2006.03.007_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.1980030205","article-title":"Therapeutic potential of HPMPC as an antiviral drug","volume":"3","author":"De Clercq","year":"1993","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2006.03.007_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2006.03.007_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.03.007_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.03.007_bib16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/AAC.45.6.1621-1628.2001","article-title":"Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside resistant HIV type 1 and select for resistance mutations that reverse AZT resistance","volume":"45","author":"Hammond","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib17","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/jm9811256","article-title":"Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base","volume":"42","author":"Holy","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.03.007_bib18","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1135\/cccc19872775","article-title":"Acyclic nucleotide analogs. Part I. Synthesis of isomeric and enantiomeric O-phosphonylmethyl derivatives of 9-(2,3-dihydroxypropyl)adenine","volume":"52","author":"Holy","year":"1987","journal-title":"Coll. Czech. Chem. Commun."},{"key":"10.1016\/j.antiviral.2006.03.007_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM199707103370207","article-title":"Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome","volume":"337","author":"Jacobson","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2006.03.007_bib20","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/AAC.48.5.1869-1871.2004","article-title":"Inhibitory activity of alkoxyalkyl and alkylesters of cidofovir acnd cyclic cidofovir against orthopoxvirus replication in vitro","volume":"48","author":"Keith","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib21","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/AAC.48.9.3516-3522.2004","article-title":"Oral treatment of murine cytomegalovirus infection with ether lipid esters of cidofovir","volume":"48","author":"Kern","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-3542(97)00039-9","article-title":"Alkoxypropane prodrugs of foscarnet. Effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV","volume":"36","author":"Kini","year":"1997","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.03.007_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","article-title":"Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir","volume":"48","author":"Quenelle","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib25","unstructured":"Vemishetti, P.R., Brodfuehrer, H.G., Howell C.S., 1997. Process for the preparation of nucleotides. US Patent 5,591,852."},{"key":"10.1016\/j.antiviral.2006.03.007_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/AAC.49.2.656-662.2005","article-title":"Comparison of the antiviral activity of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro","volume":"49","author":"Wan","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.007_bib27","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AAC.49.9.3724-3733.2005","article-title":"Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro","volume":"49","author":"Williams-Aziz","year":"2005","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635420600074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635420600074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T06:54:53Z","timestamp":1547708093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635420600074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S016635420600074X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.03.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}